Regulators issue warning over prescription-only weight-loss drug advertisements

Medical and pharmacy regulators have published an enforcement notice warning that advertisements for named prescription-only medicines (POMs) for weight-management are prohibited. The notice was published jointly by the General Pharmaceutical Council (GPhC), Medicines and Healthcare products Regulatory Agency (MHRA) and Advertising Standards Authority (ASA) on 11 April 2025. It outlined the MHRA and the GPhC’s […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.353826
Primary Topic: Obesity and Health Practices
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Regulators issue warning over prescription-only weight-loss drug advertisements

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Obesity and Health Practices

article

Regulators issue warning over prescription-only weight-loss drug advertisements

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Gender equality

Openalex Percentile: Top 87%

Obesity and Health Practices

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Regulators issue warning over prescription-only weight-loss drug advertisements · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS